Scharf Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-457,897
| Closed | -$84.1M | – | 51 |
|
|
2021
Q2 | $84.1M | Sell |
457,897
-83,762
| -15% | -$15.4M | 2.55% | 20 |
|
|
2021
Q1 | $82.8M | Buy |
541,659
+2,900
| +0.5% | +$443K | 2.87% | 20 |
|
|
2020
Q4 | $84.2M | Sell |
538,759
-10,965
| -2% | -$1.71M | 3.17% | 18 |
|
|
2020
Q3 | $62.9M | Sell |
549,724
-22,473
| -4% | -$2.57M | 2.71% | 18 |
|
|
2020
Q2 | $64.2M | Buy |
572,197
+2,852
| +0.5% | +$320K | 2.88% | 17 |
|
|
2020
Q1 | $51.1M | Buy |
+569,345
| New | +$51.1M | 2.56% | 20 |
|